作者:Umar, Muhammad Naveed、Shoaib, Muhammad、Ghias, Mehreen、Bibi, Shakila、Zahoor, Muhammad、Khan, Sher Wali、Ullah, Riaz、Ali, Essam A.、Gulfam, Naila、Shah, Syed Wadood Ali
DOI:10.1515/chem-2024-0033
日期:——
technique such as 1HNMR only. The synthesized compounds were assessed for acute toxicity test and are proved free of toxicity. The derivatives were further tested as anti-inflammatory agents by in vitro lipoxygenase enzyme inhibition studies, molecular docking, and in vivo carrageenan-induced paw edema assay, and histamine-induced edema test. The overall observations presented that compounds SK1 and SK3
在目前的工作中,通过异硫氰酸酯和二胺在干燥丙酮中的缩合反应合成了双硫脲衍生物,形成SK1(1,2-bis(氮-苯甲酰硫脲基)苯),SK2(1,3-双(氮-苯甲酰硫脲基)苯)和SK3(1,4-双(氮-苯甲酰硫脲基)苯)。通过熔点和光谱技术确认了新合成衍生物的结构,例如1仅 1HNMR。合成的化合物进行了急性毒性试验,证明无毒。通过进一步测试这些衍生物作为抗炎剂体外脂氧合酶抑制研究、分子对接和体内角叉菜胶诱导的爪水肿试验和组胺诱导的水肿试验。总体观察结果表明,化合物 SK1 和 SK3 具有良好的抗炎潜力,而化合物 SK2 则被发现是一种良好的抗炎剂。